SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The reduction in HF events with SGLT2is in patients with CKD and T2DM further expanded their indication for the prevention of HF in these patients @JavedButler1 https://t.co/P2e3Qmxe1U
SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Sep 2025 – Oct 2025Where it's discussed
-
X / Twitter33 posts
-
YouTube2 videos
AI synopsis
What people are saying
The discussions around this publication reflect a positive outlook, with posters emphasizing the significance of the research, such as references to 'expanded indications' and 'beneficial' effects, which demonstrate recognition of the potential clinical impact. The tone suggests an optimistic but cautious interest, as users refer to the study's role in guiding treatment strategies and guidelines, without expressing strong controversy or skepticism.
Most discussions recognize the publication as an important advancement in treatment guidelines, with terms like 'expanded' and 'significant' indicating broad support for the findings.
Posts demonstrate high curiosity by highlighting the broadening of clinical indications and emphasizing the relevance of the research, using words like 'further expands' and 'beneficial'.
While some posts briefly mention the research outcomes, they do not delve deeply into methodology or future implications, reflecting moderate engagement.
Participants perceive the publication as impactful, noting implications for clinical practice and guidelines, but this is expressed more as acknowledgment than with calls for immediate change.
Abstract in brief
- SGLT2 inhibitors, initially recommended for preventing and treating heart failure in patients with type 2 diabetes, have shown benefits across a broader spectrum, including HF with preserved ejection fraction, leading to expanded guidelines.
- Studies like SOLOIST-HF, EMPULSE, and EMPACT-MI demonstrate that starting SGLT2 inhibitors early during or after acute heart failure episodes can be beneficial, but stopping treatment may quickly reduce their positive effects.
- While observational reports suggest potential benefits of SGLT2 inhibitors in conditions such as cardiac amyloidosis, congenital heart disease, and pediatric heart failure, these findings require confirmation through future prospective clinical trials.]
Top posts
Most liked on X and Blueskyhttps://t.co/V9foCwsmyx
@JACCJournals @ESCardio @MountSinaiNYC @DLBHATTMD @Hragy @SantosGallegoMD @DukeVascular SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI - Metra - ESC Heart Failure https://t.co/yLhFfoRbgV
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
All mentions
SGLT2 Inhibitors in Heart Failure Prevention and Treatment
SGLT2 inhibitors, initially recommended for preventing and treating heart failure in patients with type 2 diabetes, have shown benefits across a broader spectrum, including HF with preserved ejection fraction, leading…
SGLT2 Inhibitors in Heart Failure Prevention and Management
SGLT2 inhibitors, initially recommended for patients with type 2 diabetes, have demonstrated benefits in broadening heart failure treatment, including HF with preserved ejection fraction. Early use during acute episodes…
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
@JACCJournals @ESCardio @MountSinaiNYC @DLBHATTMD @Hragy @SantosGallegoMD @DukeVascular SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI - Metra - ESC Heart Failure https://t.co/yLhFfoRbgV
RT @drbennisahmed: SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The…
SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI The reduction in HF events with SGLT2is in patients with CKD and T2DM further expanded their indication for the prevention of HF in these patients @JavedButler1 https://t.co/P2e3Qmxe1U
SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI - Metra - ESC Heart Failure - Wiley Online Library https://t.co/2bf4phvBuo
SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI - Metra - ESC Heart Failure - Wiley Online Library https://t.co/kpFpkgyvjr
https://t.co/V9foCwsmyx
AM
宇T
SU
KF
SZ
DE
C
JR
PL
DE
NM
DV
MC
BM
EC
NR
IA
DM
DD
RG
ST
L
OL
GF
DJ
S
ME
EE
UK
VH
S
KY
MA